Research Article
Peripheral Arterial Disease in Type 2 Diabetes Is Associated with an Increase in Fibrinogen Levels
Table 1
Baseline characteristics between subjects with and without PAD.
| | Non-PAD () | PAD () | value |
| Male no. (%) | 89 (42.6%) | 385 (43.4%) | 0.830 | Age | 62.49 ± 11.70 | 63.4 ± 11.09 | 0.294 | Smoking (%) | 62 (29.7%) | 287 (32.4%) | 0.453 | Alcohol use (%) | 54 (25.8%) | 197 (22.2%) | 0.036 | Diabetes duration (months) | 115.57 ± 85.03 | 112.35 ± 81.94 | 0.612 | Stroke (%) | 77 (36.8%) | 357 (40.2%) | 0.362 | Hypertension (%) | 91 (43.5%) | 599 (67.5%) | <0.001 | Weight (kg) | 65.78 ± 12.19 | 64.22 ± 11.09 | 0.073 | Height (cm) | 162.24 ± 8.57 | 161.97 ± 8.40 | 0.676 | BMI (kg/m2) | 24.90 ± 3.64 | 24.38 ± 3.43 | 0.053 | Waist circumference (cm) | 91.88 ± 11.90 | 90.04 ± 10.41 | 0.026 | Hip circumference (cm) | 96.14 ± 8.87 | 94.87 ± 9.19 | 0.072 | Waist/hip ratio | 0.95 ± 0.07 | 0.96 ± 0.29 | 0.879 | Fibrinogen (g/L) | 3.52 ± 1.20 | 4.06 ± 1.39 | <0.001 | TC (mmol/L) | 4.85 ± 2.55 | 4.65 ± 1.36 | 0.115 | TG (mmol/L) | 1.80 ± 1.39 | 1.81 ± 1.51 | 0.928 | HDL-C (mmol/L) | 1.15 ± 0.37 | 1.06 ± 0.30 | <0.001 | LDL-C (mmol/L) | 2.71 ± 0.94 | 2.71 ± 1.02 | 0.986 | HbA1c (%) | 9.41 ± 2.24 | 9.14 ± 2.21 | 0.114 |
|
|
PAD: peripheral arterial disease; BMI: body mass index; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein-cholesterol.
|